2008

Recombinant Human Erythropoietin (rhEPO) in Clinical Oncology

Scientific and Clinical Aspects of Anemia in Cancer

Editors:

ISBN: 978-3-211-25223-9 (Print) 978-3-211-69459-6 (Online)

Table of contents (34 chapters)

previous Page of 2
  1. Front Matter

    Pages i-xviii

  2. No Access

    Book Chapter

    Pages 1-66

    Physiology of erythropoiesis

  3. No Access

    Book Chapter

    Pages 67-80

    Biology of EPO and EPO-receptor

  4. No Access

    Book Chapter

    Pages 81-102

    The role of erythropoietin receptor expression on tumor cells

  5. No Access

    Book Chapter

    Pages 103-115

    Problems associated with erythropoietin receptor determination on tumor cells

  6. No Access

    Book Chapter

    Pages 117-148

    Definition, classification and characterization of anemia in cancer

  7. No Access

    Book Chapter

    Pages 149-188

    Pathophysiology of anemia in cancer

  8. No Access

    Book Chapter

    Pages 189-206

    Prevalence and incidence of anemia and risk factors for anemia in patients with cancer

  9. No Access

    Book Chapter

    Pages 207-248

    Significance of anemia in cancer chemotherapy

  10. No Access

    Book Chapter

    Pages 249-263

    Incidence and impact of anemia in radiation oncology

  11. No Access

    Book Chapter

    Pages 265-282

    Relationship between hemoglobin levels and tumor oxygenation

  12. No Access

    Book Chapter

    Pages 283-305

    Tumor hypoxia and therapeutic resistance

  13. No Access

    Book Chapter

    Pages 307-315

    Symptoms of anemia

  14. No Access

    Book Chapter

    Pages 317-367

    Impact of anemia and red blood cell transfusion on organ function

  15. No Access

    Book Chapter

    Pages 369-391

    Relationship of hemoglobin, fatigue, and quality of life in anemic cancer patients

  16. No Access

    Book Chapter

    Pages 393-405

    When to use red blood cell transfusions in cancer patients with solid tumours?

  17. No Access

    Book Chapter

    Pages 407-431

    Pharmacology, pharmacokinetics and safety of recombinant human erythropoietin preparations

  18. No Access

    Book Chapter

    Pages 433-448

    Epoetin treatment of anemia associated with multiple myeloma and non-Hodgkin’s lymphoma

  19. No Access

    Book Chapter

    Pages 449-508

    rhEPO in anemic patients with solid tumors and chemotherapy — efficacy and safety

  20. No Access

    Book Chapter

    Pages 509-530

    Early intervention with recombinant human erythropoietin for chemotherapy-induced anemia

  21. No Access

    Book Chapter

    Pages 531-539

    Recombinant human erythropoietin (rhEPO) therapy in myelodysplasia

previous Page of 2